Published in Am J Med Genet on December 19, 1997
Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90
American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70
An electrochemical detection scheme for identification of single nucleotide polymorphisms using hairpin-forming probes. Nucleic Acids Res (2002) 1.10
Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region. Mediterr J Hematol Infect Dis (2011) 0.83
Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women. J Pregnancy (2011) 0.78
Factor v leiden and inflammation. Thrombosis (2012) 0.77
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management. World J Gastroenterol (2017) 0.75
Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol (1996) 2.42
Recommended policies for uses of human tissue in research, education, and quality control. Ad Hoc Committee on Stored Tissue, College of American Pathologists. Arch Pathol Lab Med (1999) 1.96
Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears. Am J Clin Pathol (1996) 1.54
Cloning and characterization of the human type II arginase gene. Genomics (1996) 1.49
Quality control in molecular genetic testing. Nat Rev Genet (2001) 1.47
The human arginases and arginase deficiency. J Inherit Metab Dis (1998) 1.46
Detection of bcl-2/IgH rearrangements by quantitative-competitive PCR and capillary electrophoresis. Mol Diagn (2001) 1.46
Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon". Am J Surg Pathol (1995) 1.33
Molecular pathology, informed consent, and the paraffin block. Diagn Mol Pathol (1995) 1.32
Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol (1985) 1.28
Activation, transformation, and subunit structure of steroid hormone receptors. Endocr Rev (1982) 1.25
Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin Genet (2012) 1.18
The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23. Am J Hum Genet (1986) 1.17
A de novo deletion in FMR1 in a patient with developmental delay. Hum Mol Genet (1994) 1.13
Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest (1991) 1.12
Studies on the structure and function of the chicken progesterone receptor. Recent Prog Horm Res (1981) 1.12
Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes. Biochem Biophys Res Commun (1986) 1.11
Gastrointestinal lymphomas. Immunohistochemical studies on the cell of origin. Am J Surg Pathol (1985) 1.08
Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. Hum Pathol (1999) 1.05
Detection of human immunodeficiency virus (HIV) infection in formalin-fixed, paraffin-embedded tissues by DNA amplification. Nucleic Acids Res (1988) 1.03
Expression of arginase isozymes in mouse brain. J Neurosci Res (2001) 0.99
Loss of function mutations in conserved regions of the human arginase I gene. Biochem Mol Med (1996) 0.97
AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Gene Ther (2013) 0.97
In situ viral DNA hybridization in diagnostic surgical pathology. Hum Pathol (1987) 0.95
Human arginase isozymes. Isozymes Curr Top Biol Med Res (1987) 0.92
Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia. Hum Mutat (1994) 0.91
Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation. J Med Genet (2004) 0.86
Ependymoma-like tumor of the mesovarium. Arch Pathol Lab Med (1985) 0.85
Cloning and characterization of the mouse and rat type II arginase genes. Mol Genet Metab (1998) 0.85
In-frame deletions of BRCA1 may define critical functional domains. Hum Genet (2000) 0.84
Cystic fibrosis: low frequency of DF508 mutation in 2 population samples from Rio de Janeiro, Brazil. Hum Biol (1999) 0.84
Tumor necrosis factor-alpha plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation. Cell Immunol (1994) 0.84
Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines. Mol Genet Metab (2006) 0.82
Attitudes toward genetic carrier screening for cystic fibrosis among pregnant women: the role of health beliefs and avoidant coping style. Womens Health (1997) 0.81
Diversity of cystic fibrosis mutation-screening practices. Am J Hum Genet (1998) 0.81
Varicella-zoster DNA in temporal bones of patients with Ramsay Hunt syndrome. Lancet (1994) 0.81
AIDS and the heart: Review and consideration of pathogenetic mechanisms. Cardiovasc Pathol (2015) 0.80
Proficiency testing in diagnostic molecular pathology. Diagn Mol Pathol (1994) 0.80
The coming era of cancer genetic screening. Diagn Mol Pathol (1994) 0.79
The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA. Clin Genet (2012) 0.79
Friedreich's ataxia GAA repeat expansion in patients with recessive or sporadic ataxia. Neurology (1997) 0.79
Molecular genetic testing for familial Mediterranean fever. Mol Genet Metab (2000) 0.79
Rapid diagnosis of Legionella infection by a nonisotopic in situ hybridization method. Am J Clin Pathol (1991) 0.78
Demonstration of cytoplasmic tyrosinase mRNA in tissue-cultured cells by reverse transcription (RT) in situ polymerase chain reaction (PCR) and RT PCR in situ hybridization. Diagn Mol Pathol (1997) 0.78
Education and testing strategy for large-scale cystic fibrosis carrier screening. J Genet Couns (1994) 0.78
Cytomegalovirus and Rasmussen's encephalitis. Lancet (1991) 0.78
Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma. Clin Lymphoma (2000) 0.77
Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation (1997) 0.77
Application of in situ DNA hybridization technology to diagnostic surgical pathology. Pathol Annu (1987) 0.77
A PvuII RFLP for the human liver arginase (ARG1) gene. Nucleic Acids Res (1986) 0.77
Effect of an adjacent base on detection of a point mutation by restriction enzyme digestion. Somat Cell Mol Genet (1991) 0.77
Report card on molecular genetic testing: room for improvement? JAMA (1999) 0.77
A multiethnic study of Delta32ccr5 and ccr2b-V64I allele distribution in four Los Angeles populations. Diagn Mol Pathol (2001) 0.77
Molecular pathology and cancer genetic screening. West J Med (1995) 0.76
Inactivation of chick oviduct progesterone receptors. J Steroid Biochem (1980) 0.76
Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat Genet (1999) 0.75
Molecular techniques. West J Med (1993) 0.75
Pathology: in situ hybridization in diagnostic pathology. West J Med (1986) 0.75
Informativeness of VNTR genetic markers for detecting chimerism after bone marrow transplantation. Dis Markers (1989) 0.75
Reversible dissociation of chick oviduct progesterone receptor subunits. Adv Exp Med Biol (1986) 0.75
Update on informed consent for stored tissue research. Diagn Mol Pathol (1996) 0.75
Genetic linkage group (ARG1-D6S33-MYB) on chromosome 6q containing the arginase-1 and MYB genes. Cytogenet Cell Genet (1990) 0.75
Those elusive molecular diagnostics CPT codes. Diagn Mol Pathol (1997) 0.75
Diagnostic molecular genetics: current applications and future technologies. Pediatr Ann (1997) 0.75
Cystic fibrosis population carrier screening: here at last--are we ready? Genet Med (2001) 0.75
Molecular pathology: role in improving patient outcome: Overview. Arch Pathol Lab Med (1999) 0.75
Adult-onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitis. Am J Hematol (1993) 0.75
DMP News and Comment. Diagn Mol Pathol (1994) 0.75
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med (2001) 0.75
In situ regulation of pulmonary macrophage TNF-alpha mRNA expression by IL2. Chest (1993) 0.75
Pathologic evaluation of thymic hyperplasia in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Arch Pathol Lab Med (1986) 0.75
Molecular pathology 1995. Birth of an association [meeting report]. Diagn Mol Pathol (1996) 0.75
Cloning and sequencing of genomic DNA extracted from archival human temporal bone sections. Laryngoscope (1994) 0.75
Functional and molecular analysis of liver arginase promoter sequences from man and Macaca fascicularis. Somat Cell Mol Genet (1994) 0.75
Pitfalls of restriction endonuclease digestion for direct detection of point mutations. Clin Chem (1992) 0.75
Molecular temporal bone pathology: III. Genotyping of the deltaF508 deletion in the DNA of patients with cystic fibrosis. Laryngoscope (1998) 0.75
Delivery of cytosolic liver arginase into the mitochondrial matrix space: a possible novel site for gene replacement therapy. Somat Cell Mol Genet (1996) 0.75
Molecular temporal bone pathology: IV. Analysis of DNA template length using mitochondrial PCR primers. Laryngoscope (1998) 0.75
Breast and prostate cancer, 1994. Am J Clin Pathol (1994) 0.75